Processing

Please wait...

PATENTSCOPE will be unavailable a few hours for maintenance reason on Tuesday 25.01.2022 at 9:00 AM CET
Settings

Settings

Goto Application

1. WO2022004859 - ORAL PHARMACEUTICAL COMPOSITION AND METHOD FOR PRODUCING SAME

Publication Number WO/2022/004859
Publication Date 06.01.2022
International Application No. PCT/JP2021/025019
International Filing Date 01.07.2021
IPC
A61K 47/32 2006.1
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
47Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
32Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers
A61K 9/10 2006.1
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
9Medicinal preparations characterised by special physical form
10Dispersions; Emulsions
A61K 9/16 2006.1
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
9Medicinal preparations characterised by special physical form
14Particulate form, e.g. powders
16Agglomerates; Granulates; Microbeadlets
A61K 31/4439 2006.1
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
33Heterocyclic compounds
395having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
435having six-membered rings with one nitrogen as the only ring hetero atom
44Non-condensed pyridines; Hydrogenated derivatives thereof
4427containing further heterocyclic ring systems
4439containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
A61K 31/496 2006.1
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
33Heterocyclic compounds
395having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
495having six-membered rings with two nitrogen atoms as the only ring hetero atoms, e.g. piperazine
496Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene
A61K 31/517 2006.1
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
33Heterocyclic compounds
395having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
495having six-membered rings with two nitrogen atoms as the only ring hetero atoms, e.g. piperazine
505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
517ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
Applicants
  • ARTham Therapeutics株式会社 ARTHAM THERAPEUTICS INC. [JP]/[JP]
Inventors
  • 田中 晃 TANAKA, Akira
  • 鮒谷 千明 FUNATANI, Chiaki
  • 倉 健一 KURA, Kenichi
  • 木村 直 KIMURA, Naoki
Agents
  • 青木 篤 AOKI, Atsushi
  • 三橋 真二 MITSUHASHI, Shinji
  • 渡辺 陽一 WATANABE, Yoichi
  • 中島 勝 NAKAJIMA, Masaru
  • 池田 達則 IKEDA, Tatsunori
Priority Data
2020-11497802.07.2020JP
2021-01190128.01.2021JP
Publication Language Japanese (ja)
Filing Language Japanese (JA)
Designated States
Title
(EN) ORAL PHARMACEUTICAL COMPOSITION AND METHOD FOR PRODUCING SAME
(FR) COMPOSITION PHARMACEUTIQUE ORALE ET SON PROCÉDÉ DE FABRICATION
(JA) 経口用医薬組成物及びその製造方法
Abstract
(EN) Provided is a pharmaceutical composition for orally administering a pharmaceutical active ingredient which has a pH-dependent solubility profile, said pharmaceutical composition making it possible to achieve excellent scrubbing efficiency regardless of the pH inside the alimentary canal. Said oral pharmaceutical composition contains a pharmaceutical active ingredient which has a pH-dependent solubility profile, an inorganic or organic acid, and a hydrophilic polymer.
(FR) L'invention concerne une composition pharmaceutique pour l'administration orale d'un principe actif pharmaceutique qui possède un profil de solubilité dépendant du pH, ladite composition pharmaceutique permettant d'obtenir une excellente efficacité d'épuration indépendamment du pH à l'intérieur du tube digestif. Ladite composition pharmaceutique orale contient un principe actif pharmaceutique qui possède un profil de solubilité dépendant du pH, un acide inorganique ou organique et un polymère hydrophile.
(JA) pH依存性の溶解プロファイルを有する医薬活性成分を経口投与するための医薬組成物であって、消化管内pHによらず優れた吸収効率を達成することが可能な医薬組成物を提供する。斯かる経口用医薬組成物は、pH依存性の溶解プロファイルを有する医薬活性成分と、無機又は有機の酸と、親水性ポリマーとを含む。
Latest bibliographic data on file with the International Bureau